Screener
Beta Bionics BBNX Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Accrued expenses and other current liabilities | 17,194 | 22,431 |
| Operating lease liabilities | 1,591 | 1,938 |
| Deferred revenue | 1,881 | 1,557 |
| Total current liabilities | 26,017 | 30,924 |
| Operating lease liabilities, net of current portion | 4,921 | 5,365 |
| Deferred revenue, net of current portion | 3,454 | 3,297 |
| Other long-term liabilities | 1,629 | 1,547 |
| Total liabilities | 36,021 | 41,133 |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's total current liabilities?
- Beta Bionics (BBNX) reported total current liabilities of $26.02M in Q2 2026.
- How has Beta Bionics's total current liabilities changed year-over-year?
- Beta Bionics's total current liabilities increased by 33.5% year-over-year, from $19.49M to $26.02M.
- What is the long-term trend for Beta Bionics's total current liabilities?
- Over 2 years (2023 to 2025), Beta Bionics's total current liabilities has grown at a 70.8% compound annual growth rate (CAGR), from $10.61M to $30.92M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Beta Bionics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude